Related Experiment Videos
[Antihypertensive treatment in diabetics]
1Fourth Department of Medicine, Saitama Medical School.
Insights
Hypertensive diabetics face high cardiovascular disease risk. Guidelines recommend aggressive blood pressure control (<130/85 mmHg, or <125/75 mmHg with renal dysfunction) using specific antihypertensive agents to mitigate vascular complications.
Area of Science:
- Cardiology
- Nephrology
- Endocrinology
Context:
- Hypertensive individuals with diabetes mellitus are at elevated risk for cardiovascular disease.
- Current guidelines, including the Joint National Committee (JNC) VI, recommend early antihypertensive treatment.
- Specific blood pressure targets are set, with stricter goals for patients with renal dysfunction.
Purpose:
- To summarize current guidelines for managing hypertension in diabetic patients.
- To highlight recommended antihypertensive drug classes.
- To emphasize the need for vigorous blood pressure control to prevent vascular complications.
Summary:
- Epidemiological studies identify hypertensive diabetics as a high-risk group for cardiovascular disease.
- Guidelines recommend blood pressure targets <130/85 mmHg, or <125/75 mmHg with proteinuria >1 g/day.
- ACE inhibitors, calcium antagonists, and alpha-blockers are first-line agents, with lifestyle modifications considered initially in some guidelines.
Impact:
- Aggressive antihypertensive treatment in diabetics is crucial for reducing micro- and macrovascular disease.
- Adherence to established guidelines can improve patient outcomes.
- Further research may refine treatment strategies for this high-risk population.
Abstract:
Based on many epidemiological studies, hypertensive diabetics have been regarded as high risk for cardiovascular disease. The sixth Joint National Committee guideline (JNC VI) recommended to start hypotensive agents even at high normal blood pressure, i.e. over 130/85 mmHg and lower their blood pressure to less than 130/85 mmHg. If patients are associated with renal dysfunction (proteinuria of more than 1 g/day), the target blood pressure would be less than 125/75 mmHg. These target blood pressures were supported Hypertension Optimal Treatment study and/or UKPDS. ACE inhibitors, Ca-antagonists or alpha-blockers were regarded as one of the first line drugs. Japanese Society of Hypertension has established the guideline for hypertension treatment, in which almost the same recommendation has been made for diabetics except one point, i.e., at high normal blood pressure, lifestyle modification might be the initial treatment followed by hypotensive agents if their blood pressure dose not go down to less than 130/85 mmHg during the next 3-6 months. Based on these guidelines, more vigorous antihypertensive treatment would be recommended in diabetics to reduce micro- and macrovascular disease.